Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

This study has been completed.
Information provided by:
Astellas Pharma Inc Identifier:
First received: March 23, 2007
Last updated: April 15, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)